Edition:
United States

Repligen Corp (RGEN.OQ)

RGEN.OQ on NASDAQ Stock Exchange Global Select Market

31.57USD
1:05pm EST
Change (% chg)

$-0.15 (-0.47%)
Prev Close
$31.72
Open
$31.99
Day's High
$32.21
Day's Low
$31.55
Volume
23,075
Avg. Vol
105,120
52-wk High
$34.05
52-wk Low
$20.23

Latest Key Developments (Source: Significant Developments)

Repligen Q3 non-gaap EPS $0.08
Thursday, 3 Nov 2016 07:30am EDT 

Repligen Corp : Revenue for q3 of 2016 increased to $24.7 million compared to $19.8 million for q3 of 2015 . Total revenue for year 2016 is projected to be $102-$105 million . Fy2016 earnings per share view $0.44, revenue view $103.9 million -- Thomson Reuters I/B/E/S . Repligen reports third quarter 2016 financial results . Sees fy 2016 adjusted earnings per share $0.42 to $0.48 . Sees fy 2016 gaap earnings per share $0.23 to $0.29 . Q3 non-gaap earnings per share $0.08 .Q3 earnings per share $0.03.  Full Article

Repligen reports Q2 earnings per share $0.11
Thursday, 4 Aug 2016 07:30am EDT 

Repligen Corp : Q2 earnings per share $0.11 . Q2 non-GAAP earnings per share $0.16 . Q2 earnings per share view $0.13 -- Thomson Reuters I/B/E/S . Q2 revenue $29.2 million versus I/B/E/S view $24.8 million . Sees FY 2016 GAAP earnings per share $0.23 to $0.29 . Sees FY 2016 adjusted earnings per share $0.42 to $0.48 . Sees FY 2016 revenue $101 million to $105 million .FY2016 earnings per share view $0.47, revenue view $99.4 million -- Thomson Reuters I/B/E/S.  Full Article

Repligen announces pricing of $100 mln of 2.125 pct convertible senior notes due 2021
Thursday, 19 May 2016 08:41am EDT 

Repligen Corp :Repligen announces pricing of $100 million of 2.125 pct convertible senior notes due 2021.  Full Article

Repligen Corp files for mixed shelf offering - SEC filing
Wednesday, 18 May 2016 06:05pm EDT 

Repligen Corp : Repligen Corp files for mixed shelf offering, size not disclosed Source - http://bit.ly/1WExHpA Further company coverage: [RGEN.O] (Bengaluru Newsroom: +1 646 223 8780).  Full Article

Repligen to offer $100 mln of convertible senior notes
Wednesday, 18 May 2016 04:20pm EDT 

Repligen Corp :Repligen announces proposed public offering of $100 million of convertible senior notes due 2021.  Full Article

Repligen Corp announces extension of long term supply agreement for Protein A
Wednesday, 24 Feb 2016 04:59pm EST 

Repligen Corp:Announces extension of long term supply agreement for protein a.Says has extended through 2019 a key long-term supply agreement with GE healthcare for the manufacture of protein a ligands.  Full Article

Repligen Corp raises FY 2015 revenue guidance
Thursday, 6 Aug 2015 07:30am EDT 

Repligen Corp:Sees FY 2015 revenue to be in the range of $78-$82 million, an increase from previous guidance of $75-$78 million.Says revenue projection for FY 2015 is comprised exclusively of bioprocessing product sales.  Full Article

Repligen Corp raises FY 2015 guidance
Thursday, 7 May 2015 07:30am EDT 

Repligen Corp:Expects FY 2015 revenue range of $75-$78 million, an increase from previous guidance of $72-$75 million.Expects FY 2015 total income from operations to be $14-$16 million, an increase from previous guidance of $12-$14 million.Expects FY 2015 net income to be $10-$12 million, an increase from previous guidance of $8-$10 million.FY 2015 net income of $10, EBIT of $13 million and revenue of $73 million - Thomson Reuters I/B/E/S.  Full Article

Repligen Corp gives FY 2015 mixed guidance
Friday, 13 Mar 2015 07:00am EDT 

Repligen Corp:Expects FY 2015 total revenue of $72-$75 million, comprised exclusively of product sales, and reflecting 19pct-24pct sales growth.Expects FY 2015 total income from operations to be $12-$14 million.Expects FY 2015 net income to be $8-$10 million, reflecting estimated taxes of about $4 million.FY 2015 revenue of $71 million, EBIT of $15 million and net income of $12 million - Thomson Reuters I/B/E/S.  Full Article

Repligen Corp names tony hunt as next chief executive officer
Wednesday, 21 Jan 2015 07:00am EST 

Repligen Corp:Appointed Tony J. Hunt to be the company's next chief executive officer.Hunt, Repligen's Chief Operating Officer, will succeed Walter C. Herlihy, Ph.D., who will retire as President and CEO effective May 21, the date of the company's annual meeting of stockholders.  Full Article

BRIEF-Repligen Q3 non-gaap EPS $0.08

* Revenue for q3 of 2016 increased to $24.7 million compared to $19.8 million for q3 of 2015